Lee Frank D. insider trades
Lee Frank D. has filed 20 Form 4s with the SEC that we hold, for Pacira BioSciences, Inc. (PCRX) (Chief Executive Officer, Director), Bausch Health Companies Inc. (BHC) (Director), Bolt Biotherapeutics, Inc. (BOLT) (Director) and FMTX (President and CEO, Director). Across all of them we count 1 purchase worth $100.0K and 3 sales worth $430.5K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($132.8K). The largest single trade was a sale of 17,981 shares of FMTX worth $175.9K, dated 2022-02-23. The first filing on our record is dated 2021-11-19 and the latest 2026-05-26.
Pacira BioSciences, Inc. (PCRX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-08-12 | P, purchase reported on Form 4 | 8,264 | $100.0K | 2024-08-13 |
Bausch Health Companies Inc. (BHC)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-08-21 | S, sale reported on Form 4 | 15,912 | $121.9K | 2025-08-22 |
| 2026-05-19 | S, sale reported on Form 4 | 24,456 | $132.8K | 2026-05-20 |
Bolt Biotherapeutics, Inc. (BOLT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
FMTX
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-02-23 | S, sale reported on Form 4 | 17,981 | $175.9K | 2022-02-25 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1814686) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms